Coagulation Factors Alterations in Patients Undergoing Complex Thoraco-abdominal Aortic Aneurysm Repair
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Patients undergoing complex thoraco-abdominal aortic aneurysm repair.
- Who it may be relevant to
- Registry conditions: Thoraco-abdominal Aortic Aneurysm Repair, Coagulation Factors Alterations, Platelet Activation. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Greece
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Coagulation Factors Alterations in Patients Undergoing Complex Thoraco-abdominal Aortic Aneurysm Repair (CoFA-TAAA); a Prospective Observational Study
Overview
This study will evaluate the impact of complex thoraco-abdominal aortic aneurysm repair in coagulation during the immediate postoperative period in patients undergoing omplex thoraco-abdominal aortic aneurysm repair.
Detailed description
Endovascular aneurysm repair of abdominal aorta activates a significant inflammation reaction and has an impact on coagulation. Platelet activation seems to have a major role in this prothrombotic and hypercoagulable state. In complex thoraco-abdominal aortic aneurysm repair the implants are more complexed and the duration of operation longer. The main hypothesis is that all the above have a greater impact on platelet activation and coagulation alterations.
The aim of this study is the evaluation of the impact of complex thoraco-abdominal aortic aneurysm repair in coagulation during the immediate postoperative period in patients undergoing omplex thoraco-abdominal aortic aneurysm repair.
Interventions
- Other Patients undergoing complex thoraco-abdominal aortic aneurysm repair
Patients undergoing complex thoraco-abdominal aortic aneurysm repair
Primary outcome measures
- Coagulation status [Time frame: Day of surgery, 1st postoperative day, 4-5th postoperative day]
- Myocardial injury after non cardiac surgery [Time frame: Day of surgery, 1st postoperative day, 4-5th postoperative day]
- Acute kidney injury [Time frame: Day of surgery, 1st postoperative day, 4-5th postoperative day]
- Post-implantation syndrome [Time frame: Day of surgery, 1st postoperative day, 4-5th postoperative day]
- Major cardiovascular events [Time frame: Day of surgery, 1st postoperative day, 4-5th postoperative day]
- Major cardiovascular events, implant failure and death of any cause [Time frame: 30 days, 3, 6, and 12 months postoperatively]
Eligibility criteria
Inclusion criteria
- Consecutive patients undergoing complex thoraco-abdominal aortic aneurysm repair in University Hospital of Larissa, after informed consent will be included.
Exclusion criteria
- Refuse to participate
- Prior surgery within 3 months
- ASA PS > 3
- Known medical history of thrombophilia or functional platelet dysfunction
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Greece · 2 centers
- Larissa University Hospital — Larissa
- University of Thessaly — Larissa
Identifiers
NCT: NCT06432387 · CoFA-TAAA